Congress's newest member joins calls for Medicare to negotiate drug prices


The drug industry says price negotiations would hurt competition, cost jobs and threaten the success of the Part D program. And it points out that the VA is able to achieve its savings only because it limits the number of drugs available to beneficiaries.

Bonamici was sworn in Feb. 7 after winning a special election to replace Rep. David Wu, who resigned in August in the wake of a sex scandal.